| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-662-44605-8_16 |
| P698 | PubMed publication ID | 25861786 |
| P2093 | author name string | Alan Cowan | |
| Saadet Inan | |||
| George B Kehner | |||
| P304 | page(s) | 291-314 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Handbook of experimental pharmacology | Q26841924 |
| P1476 | title | Targeting Itch with Ligands Selective for κ Opioid Receptors | |
| P478 | volume | 226 |
| Q64105404 | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists |
| Q96132105 | Advances in therapeutic peptides targeting G protein-coupled receptors |
| Q28071549 | Advances in understanding itching and scratching: a new era of targeted treatments |
| Q44348819 | Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes |
| Q37583184 | Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria |
| Q99584584 | CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management |
| Q39156148 | Chronic Pruritus: Current and Emerging Treatment Options. |
| Q39125911 | Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges. |
| Q44350143 | Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats |
| Q89894404 | Distribution of functional opioid receptors in human dorsal root ganglion neurons |
| Q41722010 | Highly Potent and Selective New Diphenethylamines Interacting with the κ-Opioid Receptor: Synthesis, Pharmacology, and Structure-Activity Relationships. |
| Q52630403 | Inhibitory Gi/O-coupled receptors in somatosensory neurons: Potential therapeutic targets for novel analgesics. |
| Q49491653 | Itch and neuropathic itch |
| Q91588377 | Kappa Opioid Receptor Distribution and Function in Primary Afferents |
| Q38594826 | Malignancy-associated pruritus |
| Q90247607 | Management of Itch in the Elderly: A Review |
| Q90377640 | Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis |
| Q38602326 | New and Emerging Targeted Systemic Therapies: A New Era for Atopic Dermatitis |
| Q52580146 | Non-canonical Opioid Signaling Inhibits Itch Transmission in the Spinal Cord of Mice. |
| Q52654597 | Phoenixin: a novel brain-gut-skin peptide with multiple bioactivity. |
| Q90788710 | Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion |
| Q94673522 | Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients |
| Q38600702 | Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and Without Cocaine Dependence |
| Q52641235 | [Chronic prurigo]. |
| Q56968460 | [Treatment of chronic pruritus-what is new?] |
Search more.